+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pms60 - Clinical And Economic "Real World Analysis Of The Switching From Remicade (Infliximabe) By Remsima (Infliximab Biossimilar) Of Planserv Patients With Rheumatoid Arthritis, Ankylosing Spondylitis And Psoriatic Arthritis



Pms60 - Clinical And Economic "Real World Analysis Of The Switching From Remicade (Infliximabe) By Remsima (Infliximab Biossimilar) Of Planserv Patients With Rheumatoid Arthritis, Ankylosing Spondylitis And Psoriatic Arthritis



Value in Health 21: S297-S298




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067009291

Download citation: RISBibTeXText

DOI: 10.1016/j.jval.2018.09.1774


Related references

High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients. Clinical and Experimental Rheumatology 36(2): 254-262, 2017

THU0141A Non-Interventional Clinical Study Evaluating The Use of Golimumab in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PSA), and Ankylosing Spondylitis (AS) in A Real-Life Setting in Germany. Annals of the Rheumatic Diseases 75(Suppl 2): 232.2-232, 2016

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany. Bmj Open 8(6): E021082, 2018

AB1163Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab. Annals of the Rheumatic Diseases 74(Suppl 2): 1291.3-1292, 2015

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Annals of the Rheumatic Diseases 72(4): 517-524, 2013

SAT0130Long-term safety of adalimumab in patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, and crohns disease:. Annals of the Rheumatic Diseases 71(Suppl 3): 514.3-515, 2013

Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients. Expert Opinion on Biological Therapy 14(2): 145-150, 2014

Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis. Wiener Medizinische Wochenschrift 160(9-10): 220-224, 2010

Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire. Journal of Rheumatology 36(7): 1421-1428, 2009

Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Rheumatology 58(3): 441-446, 2019

THU0630Treatment Failure, Treatment Switching and Health-Related Quality of Life in Patients with Ankylosing Spondylitis or Psoriatic Arthritis: Results from A Large Multinational Real-World Sample in Europe and The USA. Annals of the Rheumatic Diseases 75(Suppl 2): 421.2-422, 2016

Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study. Joint Bone Spine 83(5): 607-609, 2016

Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. Journal of Rheumatology 43(12): 2120-2130, 2016

AB0456Improvement and maintenance of hemoglobin levels among rheumatoid arthritis, psoriatic arthritis & ankylosing spondylitis patients with anemia of inflammation after treatment with golimumab: 3 yr pooled analysis from golimumab rheumatology clinical program. Annals of the Rheumatic Diseases 71(Suppl 3): 663.12-663, 2013

Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors. Clinical Rheumatology 37(6): 1617-1623, 2018